Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735. (Q46127853)
Jump to navigation
Jump to search
scientific article published on 9 February 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735. |
scientific article published on 9 February 2009 |
Statements
1 reference
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735. (English)
1 reference
Hyman Muss
1 reference
Joyce O'Shaughnessy
1 reference
Joanne L Blum
1 reference
John E Pippen
1 reference
Frankie Ann Holmes
1 reference
Svetislava J Vukelja
1 reference
Kristi J McIntyre
1 reference
Michael A Savin
1 reference
Donald A Richards
1 reference
Robert G Mennel
1 reference
Kristi A Boehm
1 reference
Lina Asmar
1 reference
Stephen Jones
1 reference
James H Bordelon
1 reference
Robert L Kirby
1 reference
John Sandbach
1 reference
William J Hyman
1 reference
Wally G Meyer
1 reference
Daniel Mackey
1 reference
Stefan Riedel
1 reference
9 February 2009
1 reference
27
1 reference
8
1 reference
1177-1183
1 reference